Gen-t provides a genomics platform that streamlines R&D workflows for drug discovery and development. Their solution helps researchers analyze genomic data more efficiently, accelerating the identification of therapeutic targets and biomarkers.
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current genomic databases lack representation of diverse populations, leading to inequalities in medical advancements and missed opportunities for research and innovation. This lack of diversity hinders the development of effective and precise medicines for underrepresented groups.
Solution
Gen-t is building a genomics platform that leverages the genetic diversity of the Brazilian population to accelerate drug discovery and development. The company is establishing a large genetic bank in Latin America, aiming to include 200,000 Brazilians, to address the gap in genomic diversity. By integrating genomic, clinical, and behavioral data, Gen-t's platform enables researchers to identify variations associated with various health traits. This approach supports the development of more precise and effective medicines tailored to diverse populations. The platform includes capabilities for population and disease-specific recruitment, advanced analytics, and integration with electronic health records.
Target Audience
Gen-t's primary customers are researchers, pharmaceutical companies, and biotechnology firms seeking to develop more precise and effective medicines by leveraging the genetic diversity of the Brazilian population.
Features
- Integration of genomic, clinical, and behavioral data for comprehensive analysis
- Population and disease-specific recruitment strategies to ensure diverse representation
- Visit protocol including anthropometric measurements, vital signs, and blood collection
- Health and lifestyle questionnaire covering lifestyle, general health, and family history
- DNA and plasma sample collection and storage in a biobank
- Integration with Electronic Health Records (EMR) data from healthcare systems
- Advanced analytics capabilities, including GWAS and admixture mapping
- Longitudinal plasma samples for conducting other Omics studies